We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$42.6M
Cap. Flow
+$21.7M
Cap. Flow %
6.13%
Top 10 Hldgs %
34.16%
Holding
110
New
22
Increased
38
Reduced
31
Closed
18

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$9.24M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.06M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$7.44M
4
XRAY icon
Dentsply Sirona
XRAY
+$6.15M
5
IRTC icon
iRhythm Holdings
IRTC
+$6.03M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$8.25M
2
VWR
VWR Corporation
VWR
+$7.23M
3
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$5.2M
4
WMGI
Wright Medical Group Inc
WMGI
+$4.63M
5
HOLX
Hologic
HOLX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 88.14%
2 Financials 2.42%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBH icon
26
VanEck Biotech ETF
BBH
$400M
$5.78M 1.63%
45,999
+27,549
+149% +$3.32M
VTRS icon
27
Viatris
VTRS
$20.4B
$5.26M 1.49%
135,600
+44,500
+49% +$1.71M
COR icon
28
Cencora
COR
$60.6B
$4.36M 1.23%
46,140
-23,600
-34% -$2.1M
NVRO
29
DELISTED
NEVRO CORP.
NVRO
$4.26M 1.21%
57,261
+39,241
+218% +$3.14M
CVS icon
30
CVS Health
CVS
$133B
$3.89M 1.1%
48,300
-9,800
-17% -$774K
WBA
31
DELISTED
Walgreens Boots Alliance
WBA
$3.75M 1.06%
47,864
-28,000
-37% -$2.3M
BSX icon
32
Boston Scientific
BSX
$69.5B
$3.54M 1%
127,698
-98,500
-44% -$2.61M
MDT icon
33
Medtronic
MDT
$109B
$3.52M 0.99%
39,600
+14,700
+59% +$1.24M
KTWO
34
DELISTED
K2M Group Holdings, Inc
KTWO
$3.4M 0.96%
139,400
+21,200
+18% +$471K
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
$2.96M 0.84%
31,650
-200
-0.6% -$12.2K
CRL icon
36
Charles River Laboratories
CRL
$11.2B
$2.86M 0.81%
28,248
+4,460
+19% +$411K
AERI
37
DELISTED
Aerie Pharmaceuticals
AERI
$2.79M 0.79%
53,030
+19,700
+59% +$917K
NXTM
38
DELISTED
NxStage Medical Inc.
NXTM
$2.71M 0.77%
+108,300
New +$2.68M
EW icon
39
Edwards Lifesciences
EW
$49.6B
$2.64M 0.75%
66,948
+3,000
+5% +$110K
INCY icon
40
Incyte
INCY
$24.2B
$2.54M 0.72%
20,200
+7,000
+53% +$891K
DERM
41
DELISTED
Dermira, Inc.
DERM
$2.23M 0.63%
76,488
+45,300
+145% +$1.38M
CNC icon
42
Centene
CNC
$30.7B
$2.16M 0.61%
54,152
-31,400
-37% -$1.19M
NUVA
43
DELISTED
NuVasive, Inc.
NUVA
$2.14M 0.6%
+27,800
New +$2.08M
TEVA icon
44
Teva Pharmaceuticals
TEVA
$40.8B
$2.09M 0.59%
62,833
+10,100
+19% +$313K
TVTY
45
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$1.9M 0.54%
47,700
+15,800
+50% +$529K
GSK icon
46
GSK
GSK
$104B
$1.88M 0.53%
34,800
-70,560
-67% -$3.76M
BKD icon
47
Brookdale Senior Living
BKD
$3.49B
$1.86M 0.53%
+126,500
New +$1.75M
MNK
48
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.77M 0.5%
39,575
-30,553
-44% -$1.34M
HALO icon
49
Halozyme
HALO
$9.79B
$1.75M 0.5%
136,900
-39,200
-22% -$524K
ARA
50
DELISTED
American Renal Associates Holdings, Inc
ARA
$1.75M 0.5%
94,408
+48,430
+105% +$842K
1
2
3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Endurant Capital Management held 110 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Endurant Capital Management deployed $21.7M of net new capital in Q2 2017, opening 22 new positions and adding to 38 existing holdings. Its largest new stake was Dentsply Sirona: 97,400 shares worth $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Hologic, an estimated $4.46M trimmed.

  • Endurant Capital Management's largest Q2 2017 buy was Dentsply Sirona: 97,400 shares worth $6.32M.
  • Endurant Capital Management added most to McKesson in Q2 2017, an estimated $9.24M increase.
  • Endurant Capital Management's biggest Q2 2017 reduction was Hologic, cutting an estimated $4.46M.
  • Endurant Capital Management fully exited CATALENT, INC. in Q2 2017, selling an estimated $8.25M.
  • Endurant Capital Management's ten largest holdings make up 34% of its $354M portfolio in Q2 2017.
  • Endurant Capital Management opened 22 new positions and closed 18 in Q2 2017.
  • Endurant Capital Management's portfolio value rose 14% quarter-over-quarter to $354M.

Based on Endurant Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.